Cannabis rescheduling

By

21 Aug 2026

Cannabis ETF Surges as Trulieve Listing and DEA Hearing Loom

Money is flowing into cannabis equities at a pace this sector hasn't seen in years, and the numbers back it up. The AdvisorShares Pure US Cannabis ETF (MSOS) posted a 103.7% one-year net asset value

• MSOS

By

01 Jul 2026

DEA Hearing Opens With Case That Cannabis Poses Lower Risks Than Alcohol, Opioids

Federal attorneys arguing on behalf of the Trump administration's cannabis rescheduling proposal opened a formal DEA hearing on June 29 by presenting testimony that marijuana carries fewer overdose

• DEA hearing

By

28 May 2026

Curaleaf Executes Reverse Stock Split to Position Itself for U.S. Exchange Uplisting

Curaleaf Holdings, Inc. has approved a 1-for-3 reverse stock split of its subordinate voting shares, set to take effect on or about June 5, 2026. The move - coordinated with major U.S. stock

• Curaleaf

By

03 May 2026

Cannabis Rescheduling Stirs Senate, But Banking Reform Stays Stuck

President Trump's executive order directing the Justice Department to expedite marijuana's move from Schedule I to Schedule III of the Controlled Substances Act has prompted a rare bipartisan

• Cannabis Rescheduling